Reports
Reports
Sale
The global asthma spacers market size attained a value of USD 1.81 billion in 2023 driven by large asthmatic population, increase in government initiatives, rise in health care expenditure, rise in the number of production facilities, and widespread acceptance of pressurised metered-dose inhaler (MDI). The market is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032 to attain a value of USD 3.28 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Asthma is a key noncommunicable disease (NCD) affecting adults as well as children across the globe; it is caused due to inflammation and narrowing of minor airways present in the lungs, and may exhibit symptoms such as coughing, wheezing, shortness of breath and tightness in the chest. Asthma is reported to have affected over 260 million people in 2019, and led to over 4,60,000 deaths. Among children, asthma is one of the most common chronic illnesses. However, with the help of inhaled medicine, asthma can be controlled and people suffering from the disorder may live an active and normal life.
Asthma spacers are hollow tubes (generally made of plastic) that may be attached to the mouthpiece of an inhaler on one end; a mouthpiece or mask on the other end enables the user to inhale the medicine released by the inhaler (when the inhaler is pressed, the medicine is released from the inhaler end, and inhaled by the user on the other end). Asthma spacers work best if used with a metered dose inhaler (MDI). Spacers are gaining significant popularity in the treatment of asthma through delivery of inhaled medicines. Spacers decrease issues associated with poor inhaler technique, and greatly reduce oral absorption of inhaled corticosteroids. In the treatment of acute asthma, spacers have been reported to give results as good as those provided by nebulisers. When used with a metered dose inhaler (MDI), spacers help users inhale the right amount of medicine into the lungs and prevent medicine wastage (spacers concentrate the medicine into a tube, preventing it from leaking into the air). Spacers prolong the amount of time taken for the medicine to pass into the lungs. This gives the person more time to inhale, so the medication can enter the lungs more effectively.
Spacers also make medicine inhalation easier. Spacers are particularly useful for kids, who may find using an inhaler otherwise difficult.
The different types of spacers available in the market include Volumatic, AeroChamber, Able Spacer, Space Chamber Plus, and A2A spacer. Disposable spacers (made of paper or plastic) are also available. However, these spacers can not be cleaned, and should not be used longer than suggested by the manufacturing company. The usefulness of spacers in the treatment of respiratory disorders, along with increased availability, is expected to boost the global asthma spacers market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By spacer type, the market is segmented into:
By distribution channel, the market is divided into:
By region, the market is classified into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asthma Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Asthma Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Asthma Epidemiology (2016-2031)
5.3 Europe Asthma Epidemiology (2016-2031)
5.4 Asia-Pacific Asthma Epidemiology (2016-2031)
5.5 Latin America Asthma Epidemiology (2016-2031)
5.6 Middle East & Africa Asthma Epidemiology (2016-2031)
6 Global Asthma Spacers Market Overview
6.1 Global Asthma Spacers Market Historical Value (2017-2023)
6.2 Global Asthma Spacers Market Forecast Value (2024-2032)
7 Global Asthma Spacers Market Landscape
7.1 Asthma Spacers: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Asthma Spacers: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Distribution Channel
8 Asthma Spacers Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Asthma Spacers Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Asthma Spacers Market Segmentation
11.1 Global Asthma Spacers Market by Type
11.1.1 Market Overview
11.1.2 Volumatic
11.1.3 Aerochamber
11.1.4 InspirEase
11.1.5 Optichamber
11.1.6 Others
11.2 Global Asthma Spacers Market by Distribution Channel
11.2.1 Market Overview
11.2.2 Hospitals Pharmacy
11.2.3 Retail Pharmacy
11.2.4 Online Pharmacy
11.2.5 Others
11.3 Global Asthma Spacers Market by Region
11.3.1 Market Overview
11.3.2 North America
11.3.3 Europe
11.3.4 Asia Pacific
11.3.5 Latin America
11.3.6 Middle East and Africa
12 North America Asthma Spacers Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Asthma Spacers Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Asthma Spacers Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Asthma Spacers Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Asthma Spacers Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Funding and Investment Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Supplier Landscape
22.1 Trudell Medical International
22.1.1 Financial Analysis
22.1.2 Product Portfolio
22.1.3 Demographic Reach and Achievements
22.1.4 Mergers and Acquisitions
22.1.5 Certifications
22.2 PARI Respiratory Equipment, Inc.
22.2.1 Financial Analysis
22.2.2 Product Portfolio
22.2.3 Demographic Reach and Achievements
22.2.4 Mergers and Acquisitions
22.2.5 Certifications
22.3 Koninklijke Philips N.V
22.3.1 Financial Analysis
22.3.2 Product Portfolio
22.3.3 Demographic Reach and Achievements
22.3.4 Mergers and Acquisitions
22.3.5 Certifications
22.4 GlaxoSmithKline plc.
22.4.1 Financial Analysis
22.4.2 Product Portfolio
22.4.3 Demographic Reach and Achievements
22.4.4 Mergers and Acquisitions
22.4.5 Certifications
22.5 Intervet Inc.
22.5.1 Financial Analysis
22.5.2 Product Portfolio
22.5.3 Demographic Reach and Achievements
22.5.4 Mergers and Acquisitions
22.5.5 Certifications
22.6 Lupin
22.6.1 Financial Analysis
22.6.2 Product Portfolio
22.6.3 Demographic Reach and Achievements
22.6.4 Mergers and Acquisitions
22.6.5 Certifications
22.7 Cipla Inc.
22.7.1 Financial Analysis
22.7.2 Product Portfolio
22.7.3 Demographic Reach and Achievements
22.7.4 Mergers and Acquisitions
22.7.5 Certifications
22.8 Medical Developments International
22.8.1 Financial Analysis
22.8.2 Product Portfolio
22.8.3 Demographic Reach and Achievements
22.8.4 Mergers and Acquisitions
22.8.5 Certifications
22.9 HAAG-STREIT Group
22.9.1 Financial Analysis
22.9.2 Product Portfolio
22.9.3 Demographic Reach and Achievements
22.9.4 Mergers and Acquisitions
22.9.5 Certifications
22.10 Visiomed Group Ltd.
22.10.1 Financial Analysis
22.10.2 Product Portfolio
22.10.3 Demographic Reach and Achievements
22.10.4 Mergers and Acquisitions
22.10.5 Certifications
23 Asthma Spacers - Distribution Model (Additional Insight)
23.1 Overview
23.2 Potential Distributors
23.3 Key Parameters for Distribution Partner Assessment
24 Key Opinion Leaders (KOL) Insights (Additional Insight)
25 Company Competitiveness Analysis (Additional Insight)
25.1 Very Small Companies
25.2 Small Companies
25.3 Mid-Sized Companies
25.4 Large Companies
25.5 Very Large Companies
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the global market for asthma spacer reached a value of USD 1.81 billion.
The market is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032 to reach a value of USD 3.28 billion by 2032.
The major drivers of the market include the large asthmatic population, increase in government initiatives, rise in health care expenditure, rise in the number of production facilities, and widespread acceptance of pressurised metered-dose inhaler (MDI).
High prevalence of asthma and favourable reimbursement policies are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different types of spacers in the market are volumatic, aerochamber, inspirEase, and optichamber, among others.
The several distribution channels are hospital pharmacy, retail pharmacy, and online pharmacy.
The major players in the industry are Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, GlaxoSmithKline Plc., Lupin, Cipla Inc., and Medical Developments International, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.